Preservatives

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/26

encourage image

There's no tags or description

Looks like no tags are added yet.

27 Terms

1
New cards

What are the sterility requirements of the oral, rectal, topical, and inhaled medicinal products?

They don’t need to be sterile, but they have limits on the number of contaminants, and there must be the absence of specific microbes (e.g. absence of E.coli for oral medicinal products, absence of S.aureus for topical).

2
New cards

What are the sterility requirements of ophthalmic and parenteral medicinal products?

They must be sterile

3
New cards

What factors determine the sterility requirements of MPs?

  • Product type: Aqueous or non-aqueous formulation

  • Route of administration

  • Nature of the product: Whether it supports microbial growth and contains preservatives

  • Intended recipient: Neonates are more vulnerable than healthy adults

  • Patient condition: The presence of disease, wounds, or organ damage may increase the risk of infection


4
New cards

What microbial contaminations are encountered?

  1. Bacteria

  2. Fungi

  3. Viruses (rare)

  4. Protozoa (rare)

  5. Prions (rare)


5
New cards

What are the main characteristics of bacteria?

  • No membrane bound organelles

  • 0.5-5µm

  • Broadly divided into gram +ve and gram -ve bacteria

  • Most bacteria are non-pathogenic, but there are several important pathogens

  • Most bacteria can grow as biofilms


6
New cards

What is the medical relevance of biofilms?

Majority of infections involve cells growing in biofilms (e.g. endocarditis)

Biofilms can grow on indwelling medical devices (e.g. catheters) and on surfaces in places like hospitals

7
New cards

What is bacterial sporulation?

The process by which certain bacteria produce a highly resistant, dormant structure called an endospore when environmental conditions become unfavourable, such as when nutrients are limited.

Spores are very resistant to heat, radiation, desiccation, and chemical agents. They can survive for many years.


<p><span>T</span>he process by which certain bacteria produce a highly resistant, dormant structure called an endospore when environmental conditions become unfavourable, such as when nutrients are limited.</p><p class="MsoNormal"><span>Spores are very resistant to heat, radiation, desiccation, and chemical agents. They can survive for many years.</span></p><p></p>
8
New cards

What’s the difference between planktonic cells and biofilms?

Planktonic cells are bacteria that live individually and freely in a liquid environment and are more susceptible to antibiotics. They are more freely exposed to the antibiotic.

Biofilms are bacteria that attach to the surface and form a community surrounded by a protective matrix, and are more resistant to antibiotics.

9
New cards

What is the medical significance of fungi?

Pathogenic fungi:

  • Candida spp. can cause oral thrush

  • Dermatophytes are fungi that colonise skin, nails, hair

Non-pathogenic fungi:

  • Penicillium spp. produces penicillins


10
New cards

What are other contaminations?

  • Viruses

  • Protozoa – May infect improperly sterilized contact lenses

  • Prions – Prions are heat and chemical resistant, so are difficult to remove from medical equipment after surgery of patients with e.g. Mad Cow disease


11
New cards

What are the consequences of microbial contamination?

Health hazard – The contaminating organism or its toxins can cause disease.

Spoilage – There may be therapeutic breakdown of actives, or another component of formulation. It may also lose its aesthetic appeal, leading to non-compliance in patients.

12
New cards

What are the functions of preservatives?

The decrease the risk of microbial contamination throughout product shelf life.

13
New cards

What are some ideal properties of preservatives?

  • Broad spectrum

  • Rapid antimicrobial action

  • Chemically stable

  • Effective at product pH

  • Compatible with the formulation

  • Physically undetectable

  • Constitute a small proportion of the product

  • Safe

  • Cost effects


14
New cards

Name common examples of preservatives used in oral MPs

  • Organic acids e.g. benzoic acid, sorbic acid

  • Parabens; Esters of p-hydroxybenzoic acid e.g. propyl paraben


15
New cards

When organic acids are being used as preservatives, does pH matter?

Organic acids exist in 2 forms:

  • Unionised form - No electrical charge, lipophilic, and can pass through cell membranes more easily. This is the form mainly responsible for antimicrobial activity.

  • Ionised form – Has an electrical charge so cannot pass through cell membranes as easily.

The balance between these 2 forms depends on the pH of the product.

Organic acids work best when the pH is below their pKa, because a greater proportion of the acid remains unionised (e.g. benzoic acid has a pKa of 4.2 - at pH 3, most benzoic acid is unionised, so it has greater preservative activity, at pH 4.2, approximately 50% is unionised, at pH 6, most benzoic acid is ionised, so its preservative activity is reduced)

16
New cards

When parabens are being used as preservatives, does pH matter?

Parabens have unionized and ionized forms, but unlike organic acids, their pKa values are much higher (e.g. methylparaben has a pKa of ~8).

This means parabens can remain effective over a wider pH range than benzoic acid.

17
New cards

What are the disadvantages of parabens?

They have low solubility, making it harder to incorporate enough of the preservative into an aqueous product.

They have a slow kill rate, meaning they may inhibit or kill microorganisms relatively slowly, so they might not eliminate contamination quickly.

  • Different parabens are used in combination to improve preservative effectiveness.


18
New cards

What are the advantages of organic acids and parabens as preservatives?

  • Effective at low concentrations

  • Generally non-toxic, cheap, & stable.

  • Reasonable spectrum of activity

  • Can be bactericidal and fungicidal, but are not sporicidal

  • Physically undetectable

  • Long acting (but NOT fast acting)


19
New cards

How is preservative efficacy tested?

Via the challenge test

  1. Assess the product in its final container

  2. Deliberately contaminate the product with ~106 microorganisms per mL or g

  3. Use different types of microorganisms:
    Bacterial:  Pseudomonas aeruginosa,   Staphylococcus aureus, Escherichia coli
    Fungal:  Aspergillus niger, Candida albicans
    Osmophilic yeast:  Zygosaccharomyces rouxii

  4. Incubate and sample over 28 days

  5. Assess the viability. This means to check the microorganisms are still alive and capable of growing. The number of viable microorganisms is measured at each sampling point and compared with the original number.

  6. Compare the results with the acceptance criteria


20
New cards
<p>How do you read this table?</p><p></p>

How do you read this table?


Product type = The type of medicine being tested

Challenge organism = The type of organism you deliberately introduced into the product during testing

Acceptance criteria (A or B) = Different standards the product must meet, depending on the product category and pharmacopoeia requirements

Log reduction specified = The required reduction in the number of viable microorganisms after a particular time.

Now what does log reduction mean>

A log reduction measures how much the number of microorganisms has decreased.

1-log means there’s a 90% reduction in microorganisms. If we started with 1,000,000, then 100,00 would remain.

2-log means 99% reduction. 1,000,000, only 10,000 remains.

3-log means 99.9% remains. 1,000,000, only 1,000 remains.

The higher the log, the greater the decrease in microorganisms.

So for parenteral/ophthalmic products, bacteria, acceptance criteria A, after 6 hours there’s a 2-log reduction. The number of viable bacteria must decrease by 99% for that. After 24h, the number of viable bacteria must decreased by 99.9%.

NR means no recovery. That means <100 organisms per gram or ml or product

NI means no increase. That means < ½ log increase from the last value given for VC.

<p>Product type = The type of medicine being tested</p><p class="MsoNormal">Challenge organism = The type of organism you deliberately introduced into the product during testing</p><p class="MsoNormal">Acceptance criteria (A or B) = Different standards the product must meet, depending on the product category and pharmacopoeia requirements</p><p class="MsoNormal">Log reduction specified = The required reduction in the number of viable microorganisms after a particular time.</p><p class="MsoNormal">Now what does log reduction mean&gt;</p><p class="MsoNormal">A log reduction measures how much the number of microorganisms has decreased.</p><p class="MsoNormal">1-log means there’s a 90% reduction in microorganisms. If we started with 1,000,000, then 100,00 would remain.</p><p class="MsoNormal">2-log means 99% reduction. 1,000,000, only 10,000 remains.</p><p class="MsoNormal">3-log means 99.9% remains. 1,000,000, only 1,000 remains.</p><p class="MsoNormal">The higher the log, the greater the decrease in microorganisms.</p><p class="MsoNormal">So for parenteral/ophthalmic products, bacteria, acceptance criteria A, after 6 hours there’s a 2-log reduction. The number of viable bacteria must decrease by 99% for that. After 24h, the number of viable bacteria must decreased by 99.9%.</p><p class="MsoNormal">NR means no recovery. That means &lt;100 organisms per gram or ml or product</p><p class="MsoNormal">NI means no increase. That means &lt; ½ log increase from the last value given for VC.</p>
21
New cards
<p>Exam Q) A preserved ophthalmic product was inoculated with 10<sup>6</sup> CFU/ml <em>Candida albicans</em>, and over 28 days samples were withdrawn and a VC was obtained.</p><p class="MsoNormal">What would VC be after 7 days to meet grade A criteria?</p><p class="MsoNormal">What would VC be after 14 days to meet grade B criteria?</p><p>What would VC be after 28 days to meet grade B criteria?</p><p class="MsoNormal">What would be the VC of the inoculum?</p><p></p>

Exam Q) A preserved ophthalmic product was inoculated with 106 CFU/ml Candida albicans, and over 28 days samples were withdrawn and a VC was obtained.

What would VC be after 7 days to meet grade A criteria?

What would VC be after 14 days to meet grade B criteria?

What would VC be after 28 days to meet grade B criteria?

What would be the VC of the inoculum?


What would VC be after 7 days to meet grade A criteria?

  • Ophthalmic

  • Fungi (Candida albicans)

  • A

  • After 7 days, there needs to be a log reduction of 2.

  • Log reduction 2 = 99%

  • 99% of 106 is 990,000

  • 106 – 990,000 = 10,000

  • VC after 7 days is 104 CFU/mL

What would VC be after 14 days to meet grade B criteria?

  • Ophthalmic

  • Fungi (Candida albicans)

  • B

  • After 14 days, there needs to be a log reduction of 1.

  • Log reduction 2 = 90%

  • 90% of 106 is 900,000

  • 106 – 900,000 = 100,000

  • VC after 14 days is 105 CFU/mL

What would VC be after 28 days to meet grade B criteria?

  • Ophthalmic

  • Fungi (Candida albicans)

  • B

  • After 28 days, there needs to be a log reduction of NI.

  • NI means there must be < ½ log increase from the last value given for VC.

  • VC after 14 days is 105

  • VC after 28 days is <105.5 CFU/mL (less than ½ log increase) 

What would be the VC of the inoculum?

  • 106 CFU/mL


<p><strong>What would VC be after 7 days to meet grade A criteria?</strong></p><ul><li><p class="MsoNormal">Ophthalmic</p></li><li><p class="MsoNormal">Fungi (Candida albicans)</p></li><li><p class="MsoNormal">A</p></li><li><p class="MsoNormal">After 7 days, there needs to be a log reduction of 2.</p></li><li><p class="MsoNormal">Log reduction 2 = 99%</p></li><li><p class="MsoNormal">99% of 10<sup>6</sup> is 990,000</p></li><li><p class="MsoNormal">10<sup>6</sup> – 990,000 = 10,000</p></li><li><p class="MsoNormal">VC after 7 days is 10<sup>4</sup> CFU/mL</p></li></ul><p class="MsoNormal"><strong>What would VC be after 14 days to meet grade B criteria?</strong></p><ul><li><p class="MsoNormal">Ophthalmic</p></li><li><p class="MsoNormal">Fungi (Candida albicans)</p></li><li><p class="MsoNormal">B</p></li><li><p class="MsoNormal">After 14 days, there needs to be a log reduction of 1.</p></li><li><p class="MsoNormal">Log reduction 2 = 90%</p></li><li><p class="MsoNormal">90% of 10<sup>6</sup> is 900,000</p></li><li><p class="MsoNormal">10<sup>6</sup> – 900,000 = 100,000</p></li><li><p class="MsoNormal">VC after 14 days is 10<sup>5</sup> CFU/mL</p></li></ul><p class="MsoNormal"><strong>What would VC be after 28 days to meet grade B criteria?</strong></p><ul><li><p class="MsoNormal">Ophthalmic</p></li><li><p class="MsoNormal">Fungi (Candida albicans)</p></li><li><p class="MsoNormal">B</p></li><li><p class="MsoNormal">After 28 days, there needs to be a log reduction of NI.</p></li><li><p class="MsoNormal">NI means there must be &lt; ½ log increase from the last value given for VC.</p></li><li><p class="MsoNormal">VC after 14 days is 10<sup>5</sup></p></li><li><p class="MsoNormal">VC after 28 days is &lt;10<sup>5.5 </sup>CFU/mL (less than ½ log increase)&nbsp;</p></li></ul><p class="MsoNormal"><strong>What would be the VC of the inoculum?</strong></p><ul><li><p class="MsoNormal">10<sup>6</sup> CFU/mL</p></li></ul><p></p>
22
New cards

What factors affect the choice of preservative?

  • Intended application

  • Number and type of microorganisms present

  • Safety, stability, and cost

  • Microenvironment

  • Properties of chemical agent


23
New cards

How does the intended application affect the choice of the preservative?

  1. Product type – sterile vs. non sterile

  1. Route of administration – toxicity of preservative

  1. Moisture content

  2. Susceptibility to attack


24
New cards

How does the number and type of microorganisms present affect the choice of the preservative?

In oral products, the most likely contaminating bacteria are E.coli, S.aureus, P.aeruginosa, Clostridium sp, and the most likely contaminating fungi are Candida sp.

We want to reduce the potential of contamination through packing, and we also want to know its shelf life.

25
New cards

How does safety, stability, and cost affect the choice of the preservative?

Safety

  • safe to handle during manufacture / packaging

  • non-toxic in relation to route of administration

Stability

  • not affected by other products in formulation

  • effective over range of pH

  • effective over product shelf life

Cost effective

  • must not constitute large proportion of cost of product


26
New cards

How does the microenvironment affect the choice of the preservative?

‘Availability’ of preservative

Interaction with formulation and/or with container?

Permeation through the container & evaporation?

Partitioning into oily phase? (e.g. parabens)

  

Moisture

Products with large amounts of water are more at risk

Aim to reduce moisture content

 

Storage temp

Affects activity / stability of preservative 

Affects levels of contamination

Consider fluctuations

27
New cards

How do the physicochemical properties of the product affect the choice of the preservative?

pH of the product

Affects potency through ionisation e.g. Organic acids are inactive when ionised

Affects survival & growth of organism

Concentration / Dilution of the preservative

toxicity or very low conc. required can make preservative inappropriate